AVNS
Avanos Medical Inc
25.00$
+0.0%
vs. previous close
Closing price · As of: Jul 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +1.1% | +1.2% | -4.2% | +3.4% | -0.8% | +5.4% | -6.7% | +4.5% | +1.6% | +1.7% | +0.7% | – | |
| – | +5.9% | +3.3% | -8.9% | +6.7% | +1.8% | +3.6% | -3.2% | +6.7% | +16.6% | -1.9% | -1.2% | – | |
| – | -2.4% | -0.5% | -0.2% | +0.8% | -2.8% | +6.9% | -9.6% | +2.6% | -11.9% | +6.0% | +2.8% | – | |
| – | -10.3% | +11.5% | +2.9% | -10.0% | +14.3% | -20.8% | -5.3% | +7.4% | +0.0% | +5.2% | -14.8% | – | |
| – | -15.4% | -5.3% | +12.2% | -3.2% | -8.2% | +7.3% | -5.0% | +10.3% | -7.1% | +1.5% | -1.4% | – | |
| – | -18.6% | +4.0% | +20.1% | -9.0% | -4.2% | +13.9% | -5.0% | +2.8% | -19.8% | +157.8% | -56.5% | – | |
| – | +116.1% | -12.9% | -66.7% | +117.6% | +3.7% | -25.1% | -41.6% | +0.0% | +79.5% | -781.7% | – | – | |
| – | +34.3% | -29.8% | -6.1% | +0.0% | +3.2% | -12.5% | -25.0% | -4.8% | -10.0% | +5.6% | -21.1% | – | |
| – | – | – | -83.1% | +313.3% | +53.2% | -4,526.3% | – | -882.5% | – | – | +533.3% | – | |
| – | – | -133.9% | – | +90.0% | +89.5% | -752.8% | – | -71.0% | -77.8% | -1,350.0% | – | – | |
| – | – | – | -108.6% | – | +138.9% | -9,339.5% | – | -1,263.6% | – | – | +37.8% | – | |
| – | +50.6% | +80.9% | -32.5% | +28.8% | +18.4% | -1,766.4% | – | -398.6% | – | +30.0% | +48.5% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.